Ian T Clark
Director · 7 filings · Latest: Aug 4, 2026
BIOMARIN PHARMACEUTICAL INC
Corvus Pharmaceuticals, Inc.
Guardant Health, Inc.
Kyverna Therapeutics, Inc.
Olema Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GH | Ian T Clark | Director | Aug 4, 2026 | Sale | $158.92 | 14,180 | $2.3M | 2,975 | |
GH | Ian T Clark | Director | Aug 4, 2026 | Option Exercise | $60.63 | 9,088 | $551.0K | 17,155 | |
GH | CLARK IAN T | — | Aug 4, 2026 | Proposed Sale | $158.92 | 14,180 | $2.3M | — | |
GH | Ian T Clark | Director | Jun 17, 2026 | Option Exercise | $0.00 | 5,092 | — | 8,067 | |
GH | Ian T Clark | Director | May 20, 2026 | Sale | $106.90 | 6,876 | $735.0K | 2,975 | |
GH | CLARK IAN T | — | May 20, 2026 | Proposed Sale | $106.90 | 6,876 | $735.0K | — | |
GDRX | IAN THORNTON CLARK | — | May 13, 2026 | Proposed Sale | $2.59 | 43,100 | $111.6K | — | |
OLMA | CLARK IAN T | — | Dec 19, 2025 | Proposed Sale | $29.73 | 264,800 | $7.9M | — | |
GH | CLARK IAN T | — | Dec 5, 2025 | Proposed Sale | $107.19 | 28,611 | $3.1M | — | |
GH | CLARK IAN T | — | Jun 17, 2025 | Proposed Sale | $48.38 | 6,672 | $322.8K | — | |
GH | CLARK IAN T | — | Nov 12, 2024 | Proposed Sale | $29.45 | 8,318 | $244.9K | — |